【摘要】 目的探讨免疫学检验联合检测对类风湿关节炎患者的诊断价值。方法本文选取2018年11月—2019年12月之间,我院收治的类风湿关节炎患者共50例,定义为试验组,同期另选取在我院进行健康体检者50例作,定义为对照组,对两组患者进行类风湿性因子(rheumatoid factor,RF)、C反应蛋白(C-reactive protein,CRP)、免疫球蛋白的检测,对比两者的检测结果。结果试验组患者的类风湿因子、C反应蛋白和对照组患者差别显著,差异具有统计学意义(P<0.05);试验组患者的免疫球蛋白检测水平和对照组患者差别显著,差异具有统计学意义(P <0.05)。结论对类风湿性关节炎患者联合检测C反应蛋白、类风湿因子、免疫球蛋白有助于为临床医生提高准确的诊断,具有十分积极的应用价值,可作为有效的检测指标广泛应用。更多还原

【Abstract】 Objective To explore the diagnostic value of immunological test combined detection in patients with rheumatoid arthritis. Methods From November 2018 and December 2019, a total of 50 patients with rheumatoid arthritis treated in our hospital were selected, defined as the experimental group, during the same period, another 50 cases of health examination in our hospital were selected as the control group. Rheumatoid factor(RF), C-reactive protein,(CRP), and immunoglobulin were tested in two groups of patients, and the results were compared. Results The rheumatoid factor and C-reactive protein of the test group were significantly different from those of the control group, and the difference was statistically significant(P < 0.05). The immunoglobulin detection level of the test group was significantly different from that of the control group, and the difference was statistically significant(P < 0.05). Conclusion The combined detection of C-reactive protein, rheumatoid factor, and immunoglobulin in patients with rheumatoid arthritis is helpful to improve accurate diagnosis for clinicians. It has a very positive application value and can be widely used as an effective detection index.更多还原